Compare · NAGE vs PM
NAGE vs PM
Side-by-side comparison of Niagen Bioscience Inc. (NAGE) and Philip Morris International Inc (PM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NAGE and PM operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- PM is the larger of the two at $300.77B, about 1151.3x NAGE ($261.2M).
- Over the past year, NAGE is down 68.5% and PM is up 7.6% - PM leads by 76.1 points.
- NAGE has been more active in the news (18 items in the past 4 weeks vs 10 for PM).
- PM has more recent analyst coverage (25 ratings vs 1 for NAGE).
- Company
- Niagen Bioscience Inc.
- Philip Morris International Inc
- Price
- $3.27-3.96%
- $192.79+1.53%
- Market cap
- $261.2M
- $300.77B
- 1M return
- -4.94%
- +4.74%
- 1Y return
- -68.51%
- +7.58%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 18
- 10
- Recent ratings
- 1
- 25
Philip Morris International Inc
Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes, other nicotine-containing products, smoke-free products, and related electronic devices and accessories. The company offers IQOS smoke-free products, including heated tobacco and nicotine-containing vapor products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, and Parliament HeatSticks brands, as well as under the Fiit and Miix licensed brands. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. It markets and sells its products in the European Union, Eastern Europe, the Middle East, Africa, South and Southeast Asia, East Asia, Australia, Latin America, and Canada. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.
Latest NAGE
- Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research
- Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)
- SEC Form 424B5 filed by Niagen Bioscience Inc.
- SEC Form EFFECT filed by Niagen Bioscience Inc.
- Niagen Bioscience CEO Rob Fried to Participate in Virtual Fireside Chat to Discuss Pharmaceutical Strategy on July 15, 2026
- SVP, General Counsel Lopez Carlos Luis was granted 2,314 shares, increasing direct ownership by 103% to 4,565 units (SEC Form 4)
- Chief Financial Officer Pamir Ozan was granted 4,255 shares, increasing direct ownership by 58% to 11,627 units (SEC Form 4)
- Chief Executive Officer Fried Robert N was granted 1,106 shares, increasing direct ownership by 0.10% to 1,060,087 units (SEC Form 4)
- Niagen Bioscience Launches Pharmaceutical Program for Accelerated Aging and Rare Genetic Diseases
- Niagen Bioscience Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
Latest PM
- Philip Morris International to Host Webcast of 2026 Second-Quarter and First Six-Months Results
- Philip Morris International Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- PMI U.S. Unveils the ZYN America250 Art Series, Bringing Modern Culture to Limited-Edition Cases
- FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products
- Americans Are Losing Patience with Innovation That Doesn't Make Life Better, New Poll from PMI U.S. Finds
- Philip Morris International Inc filed SEC Form 8-K: Other Events
- SEC Form 11-K filed by Philip Morris International Inc
- Philip Morris International and Maestro Andrea Bocelli Present “Believe. Further”
- The WSJ Leadership Institute Names Philip Morris International Among “Best Companies For the Future”
- WSJ Intelligence Study: Uniquely Human Skills Deemed "Non-Replicable" in Automated Future